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Antitumour necrosis factor-α chimeric 
antibody (infliximab) inhibits activation 
of skin-homing CD4+ and CD8+ T 
lymphocytes and impairs dendritic cell 
function
The tumour necrosis factor-α block-
ing agent infliximab has been 
shown to be an effective treat-
ment for severe psoriasis and other 
immune-mediated diseases. Bedini 
et al. demonstrate that infliximab 
impairs the in vitro activation of T 
cells isolated from psoriatic plaques 
and decreases dendritic cell func-
tions. Effects are more prominent on CD8+ T lymphocytes 
as compared with CD4+ T cells, and are augmented by the 
paucity of costimulatory signals, i.e. when immature den-
dritic cells are used as an antigen-presenting cell population. 
In addition, infliximab directly affects the differentiation of 
monocyte-derived dendritic cells, thus impairing their stimu-
latory properties. Br J Dermatol 2007; 157:249–58.
Long-term culture of multibacillary 
leprosy macrophages isolated from 
skin lesions: a new model to study 
Mycobacterium leprae–human cell 
interaction
One of the most characteristic 
aspects of lepromatous leprosy 
is the extensive accumulation of 
feathery, inactive, high bacillary 
load macrophages (Virchow cells) 
occupying extensive areas of the 
body. The inability to kill these 
mycobacteria has been attributed to the absence of interferon-
γ-activating properties as a result of the Th2 immune response. 
The authors were able to isolate and culture Virchow cells for 
long periods, demonstrating functional and morphological 
changes in these cells while eliminating the bacilli. During 
culture for 7 days, cytokine mRNA expression declined while 
nitrite levels increased significantly. Br J Dermatol 2007; 
157:273–83.
Fragrance ingredient labelling in 
products on sale in the U.K.
The appropriate patch test allergens for detecting fragrance 
allergy change over time, as newer fragrances, e.g. hydroxy-
isohexyl-3-cyclohexene carboxaldehyde (Lyral™), are added 
to consumer products. Buckley’s survey of products on 
sale in the South of England in 2006 found that Lyral™ was 
labelled in 29% of products, that the well-known sensitizer 
oak moss absolute (Evernia prunastri) is present in new pres-
tige perfumes, and that new dental products contain cinna-
mal. However, the most commonly labelled fragrances were 
limonene and linalool, which are not routinely patch tested 
in the U.K., are potent sensitizers in their oxidized state and 
are being reported as significant allergens in Europe. Br J 
Dermatol 2007; 157:295–300.
Fabry disease and the skin: data from 
FOS, the Fabry outcome survey
Fabry disease is an X-linked lyso-
somal storage disorder character-
ized by accumulation of globotri-
aosylceramide. A delay of up to 10 
years between onset of symptoms 
and diagnosis is commonplace. 
Recent evidence suggests that 
both disease prevalence, and severity of symptoms in women, 
have been significantly underestimated. Orteu et al. have 
documented dermatological manifestations with reference to 
data from 714 patients (345 males, 369 females) registered on 
a multicentre European database. Overall, 78% of males and 
50% of females had one or more dermatological abnormality. 
The authors demonstrate that the presence of cutaneous vas-
cular lesions correlates with the severity of systemic manifes-
tations (pain, renal failure, cardiac disease, premature cere-
brovascular disease). Br J Dermatol 2007; 157:331–7.
Trends in melanoma epidemiology 
suggest three different types of 
melanoma
Temporal trends in 
melanoma epidemiology 
suggest the existence of 
three unrelated types of 
melanoma: type I, thick 
melanomas, with stable 
incidence, and a distri-
bution that does not support intermittent sun exposure as being 
a risk factor; type II, slow-growing melanomas of the trunk with 
a steady increase in incidence; and type III, melanomas with a 
slower increase in incidence, occurring on continuously sun-
exposed skin of older people. Type I melanomas are responsi-
ble for a great part of the mortality related to melanoma, but 
these tumours are neither accessible to prevention, as risk fac-
tors are yet not established, nor to early detection because of 
their very fast growth rate. Br J Dermatol 2007; 157:338–43.
